Holen Sie sich die Stockscreener-App
745.35
0.18%
-1.2614
Finanzdaten der Regeneron Pharmaceuticals Inc-Aktie (REGN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
3.46%
3,884.30
|
3,754.30 | 3,675.60 | 3,028.70 | 3,789.20 |
Operating Expenses
|
10.15%
3,004.40
|
2,727.50 | 2,596.10 | 2,437.00 | 2,799.00 |
| Benefits Costs and Expenses |
42.67%
2,840.60
|
1,991.00 | 2,156.90 | 2,123.70 | 2,831.10 |
| Costs And Expenses |
10.15%
3,004.40
|
2,727.50 | 2,596.10 | 2,437.00 | 2,799.00 |
| Operating Income/Loss |
14.31%
879.90
|
1,026.80 | 1,079.50 | 591.70 | 990.20 |
| Nonoperating Income/Loss |
77.76%
163.80
|
736.50 | 439.20 | 313.30 | -32.10 |
| Income/Loss From Continuing Operations Before Tax |
40.81%
1,043.70
|
1,763.30 | 1,518.70 | 905.00 | 958.10 |
| Income Tax Expense/Benefit |
34.36%
199.10
|
303.30 | 127.10 | 96.30 | 40.40 |
| Income/Loss From Continuing Operations After Tax |
42.15%
844.60
|
1,460.00 | 1,391.60 | 808.70 | 917.70 |
|
Net Income/Loss
|
42.15%
844.60
|
1,460.00 | 1,391.60 | 808.70 | 917.70 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
100.48%
-0.50
|
103.60 | 105.10 | 106.70 | -0.10 |
| Diluted Average Shares |
100.28%
-0.30
|
107.20 | 108.60 | 111.20 | -0.50 |
| Basic Earnings Per Share |
41.52%
8.24
|
14.09 | 13.24 | 7.58 | 8.54 |
| Diluted Earnings Per Share |
42.22%
7.87
|
13.62 | 12.81 | 7.27 | 8.11 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):